Detection and quantification of Plasmodium falciparum in blood samples using quantitative nucleic acid sequence-based...

Area of Science:

• Molecular Biology
• Parasitology
• Diagnostic Development

Background:

• Accurate detection and quantification of Plasmodium parasites are crucial for malaria diagnosis and treatment monitoring.
• Conventional microscopy has limitations in sensitivity, especially for low parasite densities.
• Novel molecular diagnostic tools are needed to improve malaria detection.

Purpose of the Study:

• To develop and validate a quantitative nucleic acid sequence-based amplification (QT-NASBA) assay for Plasmodium parasite detection.
• To compare the sensitivity and accuracy of QT-NASBA with conventional microscopy.
• To assess the utility of QT-NASBA for monitoring drug treatment efficacy.

Main Methods:

• Development of a QT-NASBA assay using primers and probes targeting the small-subunit rRNA gene of Plasmodium.
• Quantification achieved through coamplification of sample RNA with a modified in vitro RNA competitor in a single-tube reaction.
• Validation using whole blood samples spiked with Plasmodium falciparum and clinical samples from malaria patients.

Main Results:

• The QT-NASBA assay successfully detected and quantified Plasmodium parasite densities from 10 to 10(8) parasites/ml in whole blood.
• The assay demonstrated approximately 1,000-fold greater sensitivity compared to microscopy.
• Results from 120 clinical samples showed 93% agreement (within a 1-log difference) between QT-NASBA and microscopy.

Conclusions:

• QT-NASBA is a highly sensitive and accurate method for detecting and quantifying Plasmodium parasites.
• The assay is particularly valuable for diagnosing early-stage malaria with low parasite burdens.
• QT-NASBA holds significant potential for monitoring the effectiveness of antimalarial drug treatments.